Answers are grounded in this paper and cite their sources.
Introduction Pleomorphic dermal sarcoma (PDS) is a rare ultraviolet-associated cutaneous sarcoma predominantly affecting older men and typically arising on the scalp and other head and neck sites. This systematic review aimed to synthesize the available evidence on its clinical presentation, pathological features, management, and outcomes. Content MEDLINE via PubMed and Crossref were searched from inception through August 3, 2026. Eligible studies underwent structured data extraction, adjudication of overlapping cohorts, design-appropriate qualitative risk-of-bias assessment, and narrative synthesis. Fifty reports were included: 16 clinical cohorts or registries, five pathological or translational studies, and 29 case reports or small series. A post hoc diagnostic-stringency assessment evaluated whether contemporary diagnostic criteria reduced outcome heterogeneity. PDS predominantly affected older men and the scalp. Local recurrence rates ranged from 4.2 % to 45.2 % across heterogeneous cohorts, while a nationwide study estimated 5-year local-recurrence and metastatic risks of 17 % and 16 %, respectively. Restriction to studies applying contemporary diagnostic criteria did not eliminate heterogeneity. Recent Danish comparative registry data further supported distinguishing PDS from subcutaneous undifferentiated pleomorphic sarcoma, which exhibits a less favorable metastatic and survival profile. Complete three-dimensional surgical clearance and negative margins were consistently associated with improved outcomes. The benefit of radiotherapy remained uncertain, although it may improve local control in selected high-risk patients. Two previously published cases of advanced PDS achieved complete responses to pembrolizumab. Summary Complete surgical clearance remains the cornerstone of PDS management. Accurate diagnostic differentiation from deeper undifferentiated pleomorphic sarcoma is essential for prognostic interpretation, while high-risk disease warrants multidisciplinary management and close surveillance. Outlook Further multicenter studies using standardized diagnostic criteria, treatment protocols, and outcome reporting are needed to refine risk stratification, clarify the role of adjuvant radiotherapy, and establish the efficacy of immunotherapy in advanced PDS.
No takes yet. Share an insight, caveat, or question.
Scalia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: